Sunday November 8, 2009 5:05 AM ET
SmartMoney
Net Asset Value: 
24.54
1-Day Return: 
0.11 (0.45%)
YTD Return
as of 11/6/09: 
Up 23.94%
PRHSX 
(T Rowe Price Hlth Scienc)
Classification: Health/Biotech     Objective: Health/Biotech
Open to New Investors: Yes
Lipper Rating
Total Return
Consistent Return
Preservation
Tax Efficiency
Expense
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
NAV Chart | Growth of $10,000
Fund Chart
Total Returns (As of 11/06/2009)
 YTD1Yr3Yr5Yr10Yr
Fund 23.94 26.14 2.33 6.86 8.84
Classification 14.59 17.02 -1.33 3.01 6.37
Index (S&P 500) 20.90 21.30 -6.10 0.30 -0.70
% Rank in Class (1-best,100=worst)181981221
Fund Stats
Investment Objective:Health/Biotech
Net Assets ($Mil)NA
Inception Date:12/29/95
Manager Name, TenureKris H. Jenner, 2000
Expense Ratio: 0.86%
Sales Charge:
Load Type:
 
No Load
0.00%
0.00%
Top 10 Holdings (As of 6/30/09)
Company NameSymbol% Net Assets
Gilead Sciences Inc GILD 6.28
Alexion Pharm ALXN 3.92
Baxter International Inc BAX 3.39
Wyeth WYE 2.78
Teva Pharmaceutical Industries Ltd TEVA 2.66
Medco Health Sol MHS 2.51
Henry Schein HSIC 2.44
Roche Holding Ag RHHVF 2.37
Amgen AMGN 2.09
Wellpoint Inc WLP 2.08
% of Total Holdings 30.52
Advertisements
View Overview for: